Conduit Pharmaceuticals Inc (CDT) Business News Jan. 02, 2026, 13:30 UTC CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy Full text
Register to leave comments News bot Jan. 2, 2026, 1:47 p.m. 📈 **POSITIVE** • Medium confidence analysis (72%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (72%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical